Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[3H] sertraline binding to rat brain membranes.

B K Koe1, L A Lebel, W M Welch

  • 1Central Research Division, Pfizer Inc., Groton, CT 06340.

Psychopharmacology
|January 1, 1990
PubMed
Summary

Tritiated sertraline ([3H] sertraline) binds specifically to serotonin uptake sites in rat brains. This radiolabeled compound is a valuable tool for studying these crucial neurotransmitter transporters.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Report of Committee on the Relative Immunizing Value of Human and Bovine Vaccine Virus.

Public health papers and reports·2009
Same author

Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia.

The Journal of pharmacology and experimental therapeutics·2008
Same author

Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.

Neuropharmacology·2006
Same author

Functional characterization of CP-465,022, a selective, noncompetitive AMPA receptor antagonist.

Neuropharmacology·2002
Same author

Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile.

European journal of pharmacology·2001
Same author

Quinazolin-4-one alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists: structure-activity relationship of the C-2 side chain tether.

Journal of medicinal chemistry·2001

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Serotonin transporters (SERTs) are critical targets for antidepressant medications.
  • Radioligands are essential for characterizing drug binding sites and their densities.

Purpose of the Study:

  • To characterize the binding of tritiated sertraline ([3H] sertraline) to serotonin uptake sites in rat brain membranes.
  • To validate [3H] sertraline as a selective radioligand for SERT.

Main Methods:

  • Radioligand binding assays using rat whole brain membranes.
  • Saturation binding experiments to determine binding affinity (KD) and density (Bmax).
  • Kinetic studies and competition binding experiments with known serotonin reuptake inhibitors.

Main Results:

  • [3H] sertraline exhibited high affinity binding (KD = 0.57 nM) at a single site (nH = 1.06) in rat brain membranes.
  • Binding was reversible, with kinetic and saturation data showing good agreement.
  • Competition studies confirmed selective binding to serotonin transporters, with a potency order consistent with known inhibitors.
  • p-chloroamphetamine treatment significantly reduced ex vivo [3H] sertraline binding, indicating SERT-specific labeling.

Conclusions:

  • [3H] sertraline is a highly selective and high-affinity radioligand for serotonin uptake sites in the rat brain.
  • This radiotracer is suitable for quantitative autoradiography and in vitro characterization of SERT.
  • [3H] sertraline provides a valuable tool for research into serotonin transporter function and pharmacology.

Related Experiment Videos